Therapy of Stress cardiomyopathy:
Beta blockers are theoretically promising but they may not offer protection.
ACE inhibitors or ARBs are essential.
Anticoagulation should be considered in the presence of ventricular thrombus or embolic events.
Standard heart failure therapy is administered when needed. Early restoration of normal ventricular function is the rule, but in 5% of the patients, it can be delayed (>2 months).
Approximately 5% of patients have a recurrence 3 weeks to 4 years after the first event.
In hospital mortality is 2–4% and during longterm follow up mortality is 5.6% per year.